Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia

This study explored the relative efficacy of ibrutinib versus previous standard-of-care treatments in relapsed/refractory patients with chronic lymphocytic leukaemia (CLL), using multivariate regression modelling to adjust for baseline prognostic factors. Individual patient data were collected from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Hematol
Main Authors: Hansson, Lotta, Asklid, Anna, Diels, Joris, Eketorp-Sylvan, Sandra, Repits, Johanna, Søltoft, Frans, Jäger, Ulrich, Österborg, Anders
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5569664/
https://ncbi.nlm.nih.gov/pubmed/28762081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-017-3061-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados